Peregrine Asset Advisers’s GSK GSK Stock Holding History

Peregrine Asset Advisers’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-23,648	Closed	-$1.58M	–	121
2014 Q1	$1.58M	Buy	+23,648	New	+$1.6M	1.22%	25

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Peregrine Asset Advisers's GSK Position: Q2 2014 in Review

Peregrine Asset Advisers sold out of GSK (GSK) in Q2 2014, closing a stake of 23,648 shares — an estimated $1.58M sold.

Peregrine Asset Advisers first reported a position in GSK in Q1 2014 and held it in 1 quarter. The position peaked at $1.58M in Q1 2014. 722 funds tracked by Wall St. Rank hold GSK as of Q2 2014.

Peregrine Asset Advisers reported no remaining GSK position as of Q2 2014 after selling out during the quarter.
Peregrine Asset Advisers sold 23,648 GSK shares in Q2 2014, an estimated $1.58M.
Peregrine Asset Advisers first reported a position in GSK in Q1 2014 and held it in 1 quarter.
Peregrine Asset Advisers's GSK position peaked at $1.58M in Q1 2014.
722 funds tracked by Wall St. Rank held GSK as of Q2 2014.

Based on Peregrine Asset Advisers's 13F filing for Q2 2014, filed 14 Aug 2014.